Moderna (MRNA) Q4 earnings 2022


Moderna on Thursday missed earnings expectations for the fourth quarter, as costs rose from surplus production capacity and lower demand for its Covid-19 vaccine, the company’s only product on the market.

Moderna reported quarterly earnings of $3.61 per share, a 68% decrease from the same period in 2021 when it booked $11.29 per share. The figure fell short of the $4.68 a share Wall Street expected.

The Boston biotech company generated $5.1 billion in revenue in the fourth quarter of 2022, which was in line with analyst expectations but a 30% drop from the same period in 2021.

Moderna shares fell as much as 4% in Thursday morning trading.

Moderna has signed contracts for $5 billion in Covid…

Source cnbc.com

0 0 votes
Article Rating

UK economy in ‘a lot better shape’ than bleak figures suggest, fund manager says

Previous article

Beyond Meat (BYND) Q4 2022 earnings

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings